Featured News

Dr. Esen Sefik, PhD, an immunologist and an Associate Research Scientist in the Flavell Lab at Yale School of Medicine, is the recipient of the Celiac Disease Foundation–Takeda Early Career Research Award, an award designed to support promising early-career researchers working toward independent and productive research careers in celiac disease.  

A new study published in the journal Gastro Hep Advances finds that a considerable proportion of Black patients with biopsy-confirmed celiac disease had negative diagnostic blood tests. Traditionally perceived as predominantly affecting non-Hispanic White individuals, this study underscores the importance of bridging existing research gaps to better serve underrepresented populations. 

Did you know that there are gluten-free summer camps that offer fun and peace of mind for children and teens with celiac disease? Learn about a few of the options available this summer!

Using data from the Foundation’s iCureCeliac® Patient Registry, a new observational study helps explain the relationship between persistent celiac disease symptoms, gluten-free diet adherence, mental health, and quality of life.

In our pursuit of critical federal support for celiac disease, we understand that true progress requires a multifaceted approach. While government support is invaluable, we also recognize the power of strategic collaboration with the private sector to drive the much-needed change our community deserves.

The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications. 

The Celiac Disease Foundation and Celiac Cruise are pleased to announce an innovative partnership to offer safe and delicious gluten-free travel experiences, provide educational opportunities, and foster philanthropy within the celiac disease community.

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

As the mother of a child with celiac disease, I understand the mix of emotions that Halloween can bring for our community. Navigating school, parties, and trick-or-treating with a child with celiac disease comes with its own set of concerns.